Yunnan Biovalley Pharmaceutical Co (BJSE:920266) Shares Outstanding (Basic Average): 117.4 Mil (As of Mar. 2026)


BJSE:920266 Yunnan Biovalley Pharmaceutical Co Ltd BJSE:920266
64 GF Score
Price ¥6.43
GF Value ¥7.65
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Yunnan Biovalley Pharmaceutical Co Shares Outstanding (Basic Average)?

Yunnan Biovalley Pharmaceutical Co BJSE:920266 64 Shares Outstanding (Basic Average) is 117.4 Mil as of Mar. 2026. GuruFocus rates BJSE:920266 with a GF Score™ of 64/100 and a GF Value™ of ¥7.65 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Yunnan Biovalley Pharmaceutical Co's average basic shares outstanding for the quarter that ended in Mar. 2026 was 117.4 Mil.


Yunnan Biovalley Pharmaceutical Co  (BJSE:920266) Shares Outstanding (Basic Average) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.


Be Aware

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Yunnan Biovalley Pharmaceutical Co Shares Outstanding (Basic Average) Related Terms


Yunnan Biovalley Pharmaceutical Co Shares Outstanding (Basic Average) Historical Data

* Premium members only.

The historical data trend for Yunnan Biovalley Pharmaceutical Co's Shares Outstanding (Basic Average) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Yunnan Biovalley Pharmaceutical Co Shares Outstanding (Basic Average) Chart

Yunnan Biovalley Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Shares Outstanding (Basic Average)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 124.61 125.41 122.00 124.00 122.80

Yunnan Biovalley Pharmaceutical Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Shares Outstanding (Basic Average) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 119.77 126.71 120.85 123.89 117.38
BJSE:920266
64GF Score
Yunnan Biovalley Pharmaceutical Co Ltd BJSE:920266
Shares Outstanding (Basic Average) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Yunnan Biovalley Pharmaceutical Co Shares Outstanding (Basic Average) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that exact time point. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.

What does a Shares Outstanding (Basic Average) of 117.4 Mil mean?
Yunnan Biovalley Pharmaceutical Co (BJSE:920266) has a Shares Outstanding (Basic Average) of 117.4 Mil as of Mar. 2026. The average shares outstanding over two periods not accounting for dilutive securities like convertible bonds. View historical data on Yunnan Biovalley Pharmaceutical Co and its competitors.
Is Yunnan Biovalley Pharmaceutical Co's Shares Outstanding (Basic Average) too high?
Yunnan Biovalley Pharmaceutical Co's current Shares Outstanding (Basic Average) is 117.4 Mil. Overall, Yunnan Biovalley Pharmaceutical Co has a GF Score™ of 64/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Yunnan Biovalley Pharmaceutical Co's Shares Outstanding (Basic Average) compare to ZTS and UTHR?
Yunnan Biovalley Pharmaceutical Co's Shares Outstanding (Basic Average) of 117.4 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Outstanding (Basic Average) for a Drug Manufacturers company?
A good Shares Outstanding (Basic Average) depends on the Drug Manufacturers industry context. However, Shares Outstanding (Basic Average) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Outstanding (Basic Average) mean?
A high Shares Outstanding (Basic Average) can signal that a stock is expensive relative to its fundamentals. The average shares outstanding over two periods not accounting for dilutive securities like convertible bonds. View historical data on Yunnan Biovalley Pharmaceutical Co and its competitors. Yunnan Biovalley Pharmaceutical Co's current Shares Outstanding (Basic Average) is 117.4 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Yunnan Biovalley Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Yunnan Biovalley Pharmaceutical Co (BJSE:920266) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥7.65, compared to a current price of ¥6.43 — trading 15.9% below its estimated fair value. The current Shares Outstanding (Basic Average) is 117.4 Mil. Yunnan Biovalley Pharmaceutical Co's overall GF Score™ is 64/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Outstanding (Basic Average) calculated?
Shares Outstanding (Basic Average) is calculated from a company's financial statements. For Yunnan Biovalley Pharmaceutical Co (BJSE:920266), the current Shares Outstanding (Basic Average) is 117.4 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Yunnan Biovalley Pharmaceutical Co (BJSE:920266) Overvalued in 2026?

Based on GuruFocus' analysis, Yunnan Biovalley Pharmaceutical Co stock appears to be undervalued. The current stock price of ¥6.43 is trading 15.9% below its estimated GF Value™ of ¥7.65. GuruFocus considers Yunnan Biovalley Pharmaceutical Co to be Modestly Undervalued.

Key valuation signals for BJSE:920266:

  • Shares Outstanding (Basic Average): 117.4 Mil
  • GF Value™: ¥7.65 vs. price of ¥6.43 (15.9% below fair value)
  • GF Score™: 64/100 with 3 warning signs

No single metric tells the full story. See the BJSE:920266 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Yunnan Biovalley Pharmaceutical Co Business Description

Address No. 999 Biological Valley Street, Majinpu New District, High-tech Zone, Yunnan Province, Kunming City, CHN, 650500
Yunnan Biovalley Pharmaceutical Co Ltd engages in research and development, production, and marketing of pharmaceuticals and health care based on herbal medicines. The products on the market include breviscapine injection, breviscapine Shengmai capsules, breviscapine tablets, breviscapine dripping pills, Erigeron Capsules, Erigeron Soft Capsules.
64GF Score

Get the complete analysis for BJSE:920266

Shares Outstanding (Basic Average) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥6.43
Price
¥7.65
GF Value